期刊文献+

甲基化CpG结合域蛋白1和VIMENTIN在胰腺癌中的表达及其临床意义 被引量:3

Expressions of methyl-CpG binding domain protein 1 and VIMENTIN in pancreatic carcinoma and their clinical significance
下载PDF
导出
摘要 目的探讨甲基化CpG结合域蛋白1(MBD1)和VIMENTIN蛋白在胰腺癌组织中的表达情况及其与胰腺癌临床病理特征的关系。方法采用免疫组织化学方法检测40例经手术切除的胰腺癌组织和10例良性肿瘤患者的正常胰腺组织中MBD1和VIMENTIN蛋白的表达。结果在40例胰腺癌标本中有28例(70.0%)MBD1呈阳性表达,16例(40.0%)VIMENTIN蛋白呈阳性表达,显著高于正常胰腺组织标本的1例(1/10)和0例(P值均<0.05)。MBD1与VIMENTIN蛋白的阳性表达呈正相关(r=0.423,P=0.012)。在有淋巴结转移的胰腺癌中的MBD1表达阳性率显著高于无淋巴结转移的胰腺癌(P=0.023)。在病理分化较差和有淋巴结转移的胰腺癌中的VIMENTIN表达阳性率显著高于病理分化较好及无淋巴结转移的胰腺癌(P值分别=0.027、0.003)。结论胰腺癌组织中存在MBD1和VIMENTIN的过表达,并与病理分级和淋巴结转移有关,MBD1可能通过调控甲基化过程,干预VIMENTIN的表达,在胰腺癌的发生、发展中起到重要作用。 Objective To investigate the expressions of methyl-CpG binding domain protein 1(MBD1), VIMENTIN and their correlation with clinical pathological parameters in human pancreatic carcinoma.Methods Immunohistochemistry was used to detect the expression of MBD1 and VIMENTIN in 40 pancreatic cancer tissues and 10 normal pancreatic tissues.Results The positive rates of MBD1 and VIMENTIN in pancreatic carcinoma tissues were 28/40(70.0%) and 16/40(40.0%),respectively,which were significantly higher than those in the normal control group(1/10 and 0,both P0.05).The expression of VIMENTIN was significantly correlated with the pathological degrees(P = 0.027) and lymph node metastasis(P = 0.003) of pancreatic cancer,and the expression of MBD1 was correlated with lymph node metastasis(P = 0.023).We also found a positive correlation between MBD1 and VIMENTIN expression in pancreatic cancer(r = 0.423,P = 0.012).Conclusion MBD1 and VIMENTIN are over-expressed in human pancreatic carcinoma,which is correlated with the pathological degree and lymph node metastasis of pancreatic carcinoma.The expression of MBD1 is closely related to the metastasis of pancreatic cancer and expression of VIMENTIN.MBD1 may be involved in regulating VIMENTIN expression by mediating DNA methylation in pancreatic cancer,thus playing an important role in the carcinogenesis of the pancreatic carcinoma.
出处 《上海医学》 CAS CSCD 北大核心 2010年第11期1013-1015,I0001,共4页 Shanghai Medical Journal
关键词 胰腺癌 甲基化CpG结合域蛋白1 VIMENTIN DNA甲基化 Pancreatic neoplasms Methyl-CpG binding domain protein 1 VIMENTIN DNA Methylation
  • 相关文献

参考文献9

  • 1傅德良,龙江,金忱,虞先浚,倪泉兴.利用基因芯片和RT-PCR检测MBD1在胰腺癌中的表达[J].外科理论与实践,2005,10(3):241-244. 被引量:5
  • 2Liu C,Chen Y,Yu X,et al.Proteomic analysis of differential proteins in pancreatic carcinomas:Effects of MBD1 knock-down by stable RNA interference.BMC Cancer,2008,8:121.
  • 3Nakajima S,Doi R,Toyoda E,et al.N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.Clin Cancer Res,2004,10:4125-4133.
  • 4Lang S H,Hyde C,Reid I N,et al.Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.Prostate,2002,52:253-263.
  • 5狄扬,龙江,傅德良,虞先浚,金忱,倪泉兴,张延龄.甲基化CpG结合域蛋白1在胰腺癌组织中的表达和意义[J].外科理论与实践,2006,11(1):35-38. 被引量:4
  • 6Lopez-Serra L,Ballestar E,Fraga M F,et al.A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.Cancer Res,2006,66:8342-8346.
  • 7Patra S K,Patra A,Zhao H,et al.Methy1-CpG-DNA binding proteins in human prostate cancer:expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.Biochem Biophys Res Commun,2003,302:759-766.
  • 8Zou H,Harrington J J,Shire A M,et al.Highly methylated genes in colorectal neoplasia:implications for screening.Cancer Epidemiol Biomarkers Prev,2007,16:2686-2696.
  • 9Chen W D,Han Z J,Skoletsky J,et al.Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.J Natl Cancer Inst,2005,97:1124-1132.

二级参考文献9

  • 1Xian-Jun Yu,Jiang Long,De-Liang Fu,Qun-Hua Zhang,Quan-Xin Ni the Center for Pancreatic Cancer, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray[J].Hepatobiliary & Pancreatic Diseases International,2003,2(3):467-470. 被引量:8
  • 2Ng HH, Jeppesen P, Bird A. Active repression of methylated Genes by the chromosomal protein MBD1 [J].Molecular and Cellular Bio, 2000,20(4): 1394-1406.
  • 3Cross SH, Meehan RR, Nan X, et al. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat[J]. Genet, 1997,16(3):256-259.
  • 4Ballestar E, Wolffe AP. Methyl-CpG-bindinG proteins tarGetinG specific Gene repression [J]. Eur J Biochem,2001,268(1):1-6.
  • 5Gaubatz S, Lindeman GJ, Ishida S, et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control[J]. Mol Cell, 2000,6(3):729-735.
  • 6Esteller M, Corn PG, Baylin SB, et al. A Gene hypermethylation profile of human cancer[J]. Cancer Res, 2001,61 (8): 3225-3229.
  • 7Campanero MR, ArmstronG MI, FleminGton EK, et al.CpG methylation as a mechanism for the reGulation of E2F activity[J]. Proc Natl Acad Sci, 2000,97(12):6481-6486
  • 8Esteller M, Corn PG, Baylin SB, et al. A Gene hypermethylation profile of human cancer[J]. Cancer Res, 2001,61(8):3225-3229.
  • 9Sarraf SA, Stancheva I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly [J].Mol Cell. 2004,15(4):595-605.

共引文献6

同被引文献79

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部